Measurement of procalcitonin (PCT) is intended for use in conjunction with other laboratory findings and clinical assessments to aid in the risk assessment of critically ill patients on their first day of ICU admission for progression to severe sepsis and septic shock.1 For laboratory diagnosis, PCT is a marker enabling specific differentiation between bacterial infection and other causes of inflammatory reactions.2 The evaluation of PCT assay results must always be performed taking into consideration the patient’s history and the results of any other tests performed.
1. Package Insert, VIDAS® B•R•A•H•M•S PCT REF 30 450-01, 13975 A, 2007/08.
2. Christ-Crain M, Jaccard-Stolz D, Bingisser R, et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomized singleblinded intervention trial. Lancet. 2004 Feb 21;363(9409):600-7.
The VIDAS B•R•A•H•M•S PCT combines a one-step immunoassay sandwich method with fluorescent detection. The assay has been cleared for diagnostic use by the U.S. Food and Drug Administration.
Same day (within 8 - 12 hours from receipt of specimen), Monday through Saturday.
|Specimen Type||Order Code||CPT Code||NY Approved||Volume||Assay Range||Special Instructions|
2 mL serum
Specimens are approved for testing in New York only when indicated in the Specimen Information field above.
The CPT codes provided are based on Viracor Eurofins' interpretation of the American Medical Association's Current Procedural Terminology (CPT) codes and are provided for general informational purposes only. CPT coding is the sole responsibility of the billing party. Questions regarding coding should be addressed to your local Medicare carrier. Viracor Eurofins assumes no responsibility for billing errors due to reliance on the CPT codes illustrated in this material.